NCT03154359View on ClinicalTrials.gov

Atomoxetine PBPK-PD Clinical Study

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

December 12, 2017

Primary Completion Date

June 1, 2022

Study Completion Date

June 16, 2022

Conditions
ADHD
Interventions
DRUG

Atomoxetine Hydrochloride

Atomoxetine dose adjusted to achieve pre-defined concentration

Trial Locations (1)

64108

Children's Mercy Hospital and Clinics, Kansas City

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Children's Mercy Hospital Kansas City

OTHER

NCT03154359 - Atomoxetine PBPK-PD Clinical Study | Biotech Hunter | Biotech Hunter